DemandThere is sustained demand for medicine courses despite recent offering expansion, which enhances Afya's strength in the medicine market.
EarningsAfya reported solid results with medical courses tickets increasing 5% YoY, Adj EBITDA margin expanding 290bp YoY and adj. net income up by 29% YoY.
Market PositioningAfya is well positioned in the premium medicine market, with brand recognition being its main asset crucial for sustaining long-term medicine ticket prices.